Mark McPartland
Senior Vice President, Investor Relations
Replay available
Vistagen Therapeutics, Inc. (VTGN) Q2 2026 Earnings Call
Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Q2 2026 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Shawn Singh
President and Chief Executive Officer
Josh Prince
Chief Operating Officer
Andrew Say
Analyst, Jefferies
Miles Minter
Analyst, William Blair
Elmer Pyros
Analyst, Lucid Capital Markets
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Vistagen Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.094 Good day, everyone. Thank you for standing by. 00:00:02.094 -- 00:00:07.742 Welcome to the Vistagen Therapeutics Fiscal Year 2026 Second Quarter 00:00:07.742 -- 00:00:10.807 Corporate Update Conference Call and Webcast. 00:00:10.807 -- 00:00:13.871 Please note that today's call is being recorded. 00:00:13.871 -- 00:00:18.698 At this time, I'd like to turn the call over to your host, Mark McPartland, Senior Vice 00:00:18.698 -- 00:00:21.442 President, Investor Relations at Vistagen. 00:00:21.442 -- 00:00:23.442 Mark. 00:00:24.006 -- 00:00:27.991 Thank you, Operator. Good afternoon, everyone, and welcome to our conference call and 00:00:27.991 -- 00:00:29.647 webcast. 00:00:29.647 -- 00:00:34.592 Earlier this afternoon, we filed our quarterly report on Form 10-Q and issued a press 00:00:34.592 -- 00:00:39.858 release for our fiscal year 2026 second quarter, which ended on September 00:00:39.858 -- 00:00:42.058 30th, 2025, 00:00:42.981 -- 00:00:48.587 providing an overview on the progress in our Palisade III program for FASA-DNL 00:00:48.587 -- 00:00:54.594 and social anxiety disorder across our other clinical neuroscience programs. 00:00:54.594 -- 00:00:58.698 We encourage you to review the PR and 10-Q, which are available in the investor section 00:00:58.698 -- 00:01:00.292 of our website. 00:01:00.292 -- 00:01:04.517 Now, before we begin, please note that we will be making forelooking statements regarding 00:01:04.517 -- 00:01:09.944 our business during today's call based on our current expectations and information. 00:01:09.944 -- 00:01:13.509 These forelooking statements speak only as of today. 00:01:13.509 -- 00:01:18.475 Except, as law requires, we do not assume any duty to update any forelooking statements 00:01:18.475 -- 00:0...